The dominant and strong expression of the TNF Receptor superfamily 8 receptor CD30 by the tumor cells of many lymphoma entities and the minor and low CD30 expression by normal cells in lymphoid tissues has made this molecule an important target for the diagnosis and treatment of lymphomas expressing CD30. Here, TNFRSF8 is linked to neoplasm.